- Home
- VRAX vs LDWY Comparison
VRAX vs LDWY Comparison
Compare VRAX & LDWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAX
- LDWY
- Stock Information
- Founded
- VRAX 2013
- LDWY 1990
- Country
- VRAX United Kingdom
- LDWY United States
- Employees
- VRAX N/A
- LDWY N/A
- Industry
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- LDWY Advertising
- Sector
- VRAX Health Care
- LDWY Consumer Discretionary
- Exchange
- VRAX Nasdaq
- LDWY Nasdaq
- Market Cap
- VRAX 4.4M
- LDWY 9.2M
- IPO Year
- VRAX 2022
- LDWY 1991
- Fundamental
- Price
- VRAX $0.65
- LDWY $5.15
- Analyst Decision
- VRAX Strong Buy
- LDWY
- Analyst Count
- VRAX 1
- LDWY 0
- Target Price
- VRAX $3.00
- LDWY N/A
- AVG Volume (30 Days)
- VRAX 1.4M
- LDWY 5.5K
- Earning Date
- VRAX 01-01-0001
- LDWY 08-28-2025
- Dividend Yield
- VRAX N/A
- LDWY N/A
- EPS Growth
- VRAX N/A
- LDWY N/A
- EPS
- VRAX N/A
- LDWY 1.66
- Revenue
- VRAX $6,331.00
- LDWY $71,244,000.00
- Revenue This Year
- VRAX $217,274.83
- LDWY N/A
- Revenue Next Year
- VRAX N/A
- LDWY N/A
- P/E Ratio
- VRAX N/A
- LDWY $3.03
- Revenue Growth
- VRAX N/A
- LDWY 187.12
- 52 Week Low
- VRAX $0.52
- LDWY $3.02
- 52 Week High
- VRAX $3.62
- LDWY $6.19
- Technical
- Relative Strength Index (RSI)
- VRAX 45.86
- LDWY 45.96
- Support Level
- VRAX $0.54
- LDWY $4.64
- Resistance Level
- VRAX $0.59
- LDWY $5.35
- Average True Range (ATR)
- VRAX 0.06
- LDWY 0.33
- MACD
- VRAX 0.01
- LDWY -0.07
- Stochastic Oscillator
- VRAX 50.76
- LDWY 32.90
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two industries: Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.